Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 170


A new mechanism of resistance of HIV-2 to integrase inhibitors: a 5 amino-acids insertion in the integrase C-terminal domain.

Le Hingrat Q, Collin G, Lê M, Peytavin G, Visseaux B, Bertine M, Tubiana R, Karmochkine M, Valin N, Collin F, Lemaignen A, Bernard L, Damond F, Matheron S, Descamps D, Charpentier C; ANRS CO5 HIV-2 Cohort.

Clin Infect Dis. 2018 Nov 1. doi: 10.1093/cid/ciy940. [Epub ahead of print]


Dietary and Microbial Oxazoles Induce Intestinal Inflammation by Modulating Aryl Hydrocarbon Receptor Responses.

Iyer SS, Gensollen T, Gandhi A, Oh SF, Neves JF, Collin F, Lavin R, Serra C, Glickman J, de Silva PSA, Sartor RB, Besra G, Hauser R, Maxwell A, Llebaria A, Blumberg RS.

Cell. 2018 May 17;173(5):1123-1134.e11. doi: 10.1016/j.cell.2018.04.037.


Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial.

Italiano A, Touati N, Litière S, Collin F, Pourquier P, Gronchi A.

Cancer Med. 2018 May;7(5):1575-1577. doi: 10.1002/cam4.1403. Epub 2018 Apr 15.


First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).

Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G; France REcherche Nord&Sud Sida-Hiv Hépatites (ANRS) 159 HIV-2 Trial Study Group .

Clin Infect Dis. 2018 Sep 28;67(8):1161-1167. doi: 10.1093/cid/ciy245.


Oxidative stress as a biomarker for Alzheimer's disease.

Collin F, Cheignon C, Hureau C.

Biomark Med. 2018 Mar;12(3):201-203. doi: 10.2217/bmm-2017-0456. Epub 2018 Feb 13. No abstract available.


Tuning the MnII2/MnIII2 redox cycle of a phenoxo-bridged diMn catalase mimic with terminal carboxylate donors.

Solís V, Palopoli C, Daier V, Rivière E, Collin F, Moreno DM, Hureau C, Signorella S.

J Inorg Biochem. 2018 May;182:29-36. doi: 10.1016/j.jinorgbio.2018.01.013. Epub 2018 Feb 2.


Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.

Penel N, Coindre JM, Giraud A, Terrier P, Ranchere-Vince D, Collin F, Guellec SLE, Bazille C, Lae M, de Pinieux G, Ray-Coquard IL, Bonvalot S, Cesne ALE, Robin YM, Stoeckle E, Toulmonde M, Blay JY.

Cancer. 2018 Mar 15;124(6):1179-1187. doi: 10.1002/cncr.31176. Epub 2017 Dec 6.


Oxidative stress and the amyloid beta peptide in Alzheimer's disease.

Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F.

Redox Biol. 2018 Apr;14:450-464. doi: 10.1016/j.redox.2017.10.014. Epub 2017 Oct 18. Review.


Identification of key structural features of the elusive Cu-Aβ complex that generates ROS in Alzheimer's disease.

Cheignon C, Jones M, Atrián-Blasco E, Kieffer I, Faller P, Collin F, Hureau C.

Chem Sci. 2017 Jul 1;8(7):5107-5118. doi: 10.1039/c7sc00809k. Epub 2017 May 4.


New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification.

Bertine M, Gueudin M, Mélard A, Damond F, Descamps D, Matheron S, Collin F, Rouzioux C, Plantier JC, Avettand-Fenoel V.

J Clin Microbiol. 2017 Sep;55(9):2850-2857. doi: 10.1128/JCM.00755-17. Epub 2017 Jul 12.


Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.

Young RJ, Litière S, Lia M, Hogendoorn PCW, Fisher C, Mechtersheimer G, Daugaard S, Sciot R, Collin F, Messiou C, Grünwald V, Gronchi A, van der Graaf W, Wardelmann E, Judson I.

Acta Oncol. 2017 Jul;56(7):1013-1020. doi: 10.1080/0284186X.2017.1315173. Epub 2017 Apr 21.


PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.

Bertucci F, Finetti P, Perrot D, Leroux A, Collin F, Le Cesne A, Coindre JM, Blay JY, Birnbaum D, Mamessier E.

Oncoimmunology. 2017 Feb 8;6(3):e1278100. doi: 10.1080/2162402X.2016.1278100. eCollection 2017.


Thermochemistry and kinetics of graphite oxide exothermic decomposition for safety in large-scale storage and processing.

Qiu Y, Collin F, Hurt RH, Külaots I.

Carbon N Y. 2016 Jan;96:20-28. doi: 10.1016/j.carbon.2015.09.040. Epub 2015 Sep 11.


Metal-catalyzed oxidation of Aβ and the resulting reorganization of Cu binding sites promote ROS production.

Cheignon C, Faller P, Testemale D, Hureau C, Collin F.

Metallomics. 2016 Oct 1;8(10):1081-1089.


Zinc(II) Binding Site to the Amyloid-β Peptide: Insights from Spectroscopic Studies with a Wide Series of Modified Peptides.

Alies B, Conte-Daban A, Sayen S, Collin F, Kieffer I, Guillon E, Faller P, Hureau C.

Inorg Chem. 2016 Oct 17;55(20):10499-10509. Epub 2016 Sep 26.


[Sarcoma developed in irradiated area: Preliminary results of the SARI trial].

Maingon P, Mirjolet C, Diallo I, Veres C, Collin F, Italiano A, Chibon F, Merlin JL, Coindre JM.

Cancer Radiother. 2016 Oct;20(6-7):690-3. doi: 10.1016/j.canrad.2016.07.071. Epub 2016 Sep 3. French.


Prevalence and factors associated with discordant intima-media thickness and arterial stiffness combined measurements in people living with HIV.

Jean M, Saada M, Collin F, Roustant F, Aumaître H.

Infect Dis (Lond). 2016 Nov-Dec;48(11-12):857-9. doi: 10.1080/23744235.2016.1201854. Epub 2016 Jul 8. No abstract available.


Is ascorbate Dr Jekyll or Mr Hyde in the Cu(Aβ) mediated oxidative stress linked to Alzheimer's disease?

Cheignon C, Collin F, Faller P, Hureau C.

Dalton Trans. 2016 Aug 9;45(32):12627-31. doi: 10.1039/c6dt01979j.


A phase III study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm.

Khemissa F, Mineur L, Amsellem C, Assenat E, Ramdani M, Bachmann P, Janiszewski C, Cristiani I, Collin F, Courraud J, de Forges H, Dechelotte P, Senesse P.

Dig Liver Dis. 2016 Mar;48(3):327-32. doi: 10.1016/j.dld.2015.11.025. Epub 2015 Dec 15.


Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting.

Wardelmann E, Haas RL, Bovée JV, Terrier P, Lazar A, Messiou C, LePechoux C, Hartmann W, Collin F, Fisher C, Mechtersheimer G, DeiTos AP, Stacchiotti S, Jones RL, Gronchi A, Bonvalot S.

Eur J Cancer. 2016 Jan;53:84-95. doi: 10.1016/j.ejca.2015.09.021. Epub 2015 Dec 14.


Supplemental Content

Loading ...
Support Center